RxDoctor Payments Data

Aaron Thiessen, MD

Otolaryngology · Wichita, KSNPI 1043659527

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Intersect ENT, Inc. at 42.6% of the total. Reporting peaked in 2019 at $253 and has fallen 62.5% since, to $95 in 2025. That places this record below the midpoint for otolaryngology clinicians in KS, where the typical reported total is $1,279.

$558in general payments, 2019–2025

Across 16 payments — averaging $34.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$238
  • Aerin Medical Inc.$95
  • Regeneron Healthcare Solutions, Inc.$53
  • Osiris Therapeutics Inc.$47
  • Smith+Nephew$43
  • Acclarent, Inc$42
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$558100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$558 in reported general payments places this provider in the 35th percentile of 87 otolaryngology providers in Kansas.

See all otolaryngology providers in Kansas

Medicare billing

Part B allowed, 2024
$173,610
Medicare patients
400
Services billed
2,202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$52,062
Ipratropium Bromide137$3,258
Pilocarpine Hcl55$3,234
Azelastine Hcl105$2,489
Famotidine266$2,173
Montelukast Sodium264$1,465
Pantoprazole Sodium176$1,391
Fluticasone Propionate87$1,172
Levocetirizine Dihydrochloride83$787
Mupirocin108$758
Doxycycline Hyclate37$608
Clotrimazole16$383
Lidocaine Hcl ViscousLidocaine Hcl13$366
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$234
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$220

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →